Testosterone Decline in Women in NYC: Why It's Often Overlooked and How RHPNY Addresses It

When most people think of testosterone, they picture a male hormone associated with muscle mass and athletic performance. The reality is more nuanced: testosterone is critically important for women's health too, and its gradual decline—beginning in the late twenties and accelerating through perimenopause—is one of the most underrecognized contributors to fatigue, low libido, mood changes, and loss of muscle tone that women experience as they age.

Why Women Need Testosterone

Testosterone in women plays a number of important physiological roles:

• Energy and vitality: Even modest declines in free testosterone are associated with significant reductions in energy and motivation.
• Sexual function: Libido, arousal, and sexual satisfaction in women are closely tied to testosterone levels—arguably more so than estrogen.
• Muscle mass and bone density: Testosterone is anabolic; it helps women maintain lean muscle and supports skeletal strength.
• Mood and cognitive clarity: Low testosterone in women is associated with depression, brain fog, and difficulty concentrating.
• Cardiovascular health: Testosterone supports endothelial function and may play a protective role in cardiovascular risk.

How Testosterone Declines in Women

Women produce testosterone primarily in the ovaries and adrenal glands. Peak levels occur in the early twenties, and by age 40, a woman typically has roughly half the testosterone she had at 20. The decline is gradual but relentless.

Perimenopause and menopause accelerate this process. Oral contraceptive use can suppress testosterone significantly through elevation of sex hormone-binding globulin (SHBG), which binds free testosterone and renders it biologically inactive. Chronic stress, poor sleep, and nutritional deficiencies can all further depress levels.

The Problem with Standard Testing

Most routine blood panels check total testosterone, which misses the critical distinction between total and free testosterone. SHBG binds testosterone tightly; a woman may have a technically "normal" total testosterone but extremely low free (biologically active) testosterone.

At RHPNY, testosterone evaluation includes total testosterone, free testosterone, SHBG, and DHEA-S—the precursor hormone that feeds testosterone synthesis in the adrenal pathway. This comprehensive assessment gives Dr. Dhaliwal a complete picture of your androgenic status.

Signs of Low Testosterone in Women

• Persistent fatigue not explained by thyroid or sleep disorders
• Markedly reduced interest in sex
• Difficulty building or maintaining muscle despite exercise
• Increased fat deposition, especially around the abdomen
• Low motivation, flat mood, or mild depression
• Brain fog and difficulty concentrating
• Reduced sense of well-being and drive

These symptoms frequently overlap with other hormonal imbalances—which is why RHPNY evaluates the full hormone panel, including estrogen, progesterone, DHEA, cortisol, and thyroid, rather than addressing testosterone in isolation.

How RHPNY Addresses Testosterone Decline in Women

Hormone optimization at RHPNY is individualized. Dr. Dhaliwal works with each patient to determine whether the clinical picture warrants testosterone support and, if so, what delivery method is most appropriate.

Low-Dose Testosterone Therapy Options

• Transdermal cream or gel: Applied daily to thin skin (inner wrist, inner thigh), providing steady physiologic levels. Most common first-line approach in women.
• Pellet therapy: Biodegradable pellets inserted subcutaneously (typically the hip) that release testosterone consistently over 3-6 months—eliminating daily application.
• DHEA supplementation: For women with low DHEA-S, oral or topical DHEA can support natural testosterone synthesis as a gentler starting point.

All testosterone protocols at RHPNY use doses calibrated to women's physiology—far lower than male therapeutic doses. The goal is restoration to optimal physiologic levels, not supraphysiologic enhancement.

Monitoring and Safety

Testosterone therapy in women requires ongoing monitoring. Follow-up labs at 6-8 weeks after initiation check levels and look for early signs of excess (acne, facial hair, voice changes). RHPNY adjusts dosing based on both lab values and clinical response.

Long-term, testosterone therapy is well tolerated at physiologic doses in women. Current evidence does not support concerns about cardiovascular risk at these doses, and quality-of-life improvements are often substantial.

Integrating Testosterone Into a Broader Hormone Plan

Testosterone doesn't work in isolation. At RHPNY, hormone optimization considers the interplay between testosterone, estrogen, progesterone, thyroid, and adrenal hormones. A woman whose testosterone is low but whose cortisol is chronically elevated, for example, may need adrenal support before testosterone therapy is truly effective.

This systems-level approach—rather than prescribing a single hormone based on a single lab value—distinguishes RHPNY's practice from transactional hormone clinics.

Schedule a hormone consultation at RHPNY in NYC to get a comprehensive assessment of your androgen and hormone status.

--- This article is for informational purposes only and does not constitute medical advice. Hormone therapy should be supervised by a qualified physician based on your individual clinical presentation and lab results.